Europe

Aurobindo Pharma is one of the leading generic pharma companies in Europe. It ranks among the top 10 generic companies in EU/UK (source: IQVIA data MAT Q3 2024). It is also the largest Indian Pharma company in terms of revenue from Europe (source: IQVIA data MAT Q3 2024).

The company has a full-fledged Pharmacy, Hospital and Tender sales infrastructure and operations in 10 countries (France, Germany, UK, Spain, Portugal, Italy, Netherlands, Belgium, Poland and Malta) with commercialized 550+ INNs thus addressing more than 80% of total European pharmaceutical market.

Our large product portfolio covers a broad base of therapeutic segments including CVS, CNS, Gastrointestinal, Antibiotics, Respiratory, Anti-diabetics, Pain management, Oncology, local anaesthetics, as well as commodity OTC and food supplements. We are also uniquely positioned to benefit from inhouse API capabilities for a wide range of products.

Our commercial infrastructure for Europe includes

High-capacity batch testing and release facility at Malta with testing capabilities for Oral solids (Over 14,000 batches per year), Sterile injectables and Oncology products (Over 1,000 batches per year).

Logistics Hub/ Warehouse near Lyon, France with over 25,000 square metres space.

High quality oral products manufacturing site in Portugal (Generis) with a capacity of producing 1.2 billion units (tablets, sachets or capsules).

Our strength in our key markets uniquely positions us to cater to the demand of a wide range of pharmaceutical products across the continent.

France France

France leads a strong presence with a team of over 123 Reps and KAMs covering Hospitals, Branded, Retail and OTC markets.Rank #1 by volume for hospital segment; #5 in the retail market.

PORTUGAL PORTUGAL

Leading presence in Hospital, OTC and Retail segments and a strong nation-wide field force.Rank #1: Gx Retail in value; Rank #1 Hospital Market in units.

POLAND POLAND

Well-established presence in Retail reimbursement as well as non-reimbursement market, OTC, Food Supplement and Hospital segment.Strong field-force team of > 200, including CNS and Urology speciality teams and a market leader in Urology.

ITALY ITALY

Established presence in Retail and Hospital, with a field force having a nation-wide coverage of pharmacies.Rank #8 in the market; fastest growing generic company.

UK UK

Leading presence in retail covering top wholesalers and pharmacy groups and NHS (tenders). Rank #7 in the market.

GERMANY GERMANY

Established presence in Retail and Hospital. Rank #7 in retail segment.

SPAIN SPAIN

Established presence in Retail and Hospital. 9th largest generic company;fastest growing among Top 20 generic companies.

NETHERLANDS THE NETHERLANDS

Leading presence in Hospital, OTC and Retail segments; strong growth in dose dispensing market. 4th largest generic company and ranked #1 in OTC segment.

BELGIUM BELGIUM

5th largest generic company in retail segment.

We have a robust product pipeline including upcoming launches in Day-1s, injectables, respiratory, biosimilar and other niche segments.

Footer Logo

REGISTERED OFFICE

Plot no. 2, Maitrivihar, Ameerpet, Hyderabad-500038, Telangana, India.

CORPORATE OFFICE

Galaxy, Floors: 22-24, Plot No.1, Survey No.83/1, Hyderabad Knowledge City,
Raidurg Panmaktha, Rangareddy District,
Hyderabad - 500032, Telangana, India.

© Copyright 2025 Aurobindo Pharma Limited. All rights reserved.